Paradigm Biopharmaceuticals Ltd.ASX: PAR

Positive top-line results from preclinical study in ards

Oct 13, 2021 at 1:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment